4//SEC Filing
Jordan Julie 4
Accession 0000950170-23-039299
CIK 0001661998other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 9:39 PM ET
Size
19.1 KB
Accession
0000950170-23-039299
Insider Transaction Report
Form 4
Jordan Julie
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-08-03+1,548→ 4,318 total - Sale
Common Stock
2023-08-03$1.39/sh−436$606→ 3,882 total - Exercise/Conversion
Common Stock
2023-08-03+387→ 4,269 total - Exercise/Conversion
Restricted Stock Units
2023-08-03−1,548→ 0 total→ Common Stock (1,548 underlying) - Exercise/Conversion
Restricted Stock Units
2023-08-03−4,644→ 0 total→ Common Stock (4,644 underlying) - Sale
Common Stock
2023-08-03$1.39/sh−109$152→ 4,160 total - Exercise/Conversion
Common Stock
2023-08-03+4,644→ 8,804 total - Sale
Common Stock
2023-08-03$1.39/sh−1,308$1,818→ 7,496 total - Exercise/Conversion
Restricted Stock Units
2023-08-03−387→ 0 total→ Common Stock (387 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
- [F2]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
- [F3]The sales reported in the Form 4 were effected pursuant to a mandatory sell to cover arrangement solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
- [F4]Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited.
- [F5]Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such restricted stock units would have become fully vested on January 1, 2026. The remaining restricted stock units have been automatically cancelled and forfeited.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001968554
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 9:39 PM ET
- Size
- 19.1 KB